BioSpace News Archive

Business

BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle

The German biotech is trying to deepen its pipeline in cancer and other infectious diseases as COVID-19 markets contract and the international public health emergency comes to an end.

May 8, 2023
·
2 min read
·
Tristan Manalac
Business

Update: Takeda Cuts Jobs in California Following Massachusetts Layoffs

Takeda told BioSpace that the California layoffs are directly related to the recent cuts in Massachusetts.

May 8, 2023
·
2 min read
·
Rosemary Scott
Business

Eisai Pays up to $2B for ADC Bearing Its Halaven as Payload

The deal with BlissBio is the latest in a cascade of multi-million- and billion-dollar acquisitions and collaborations centered on antibody-drug conjugates.

May 8, 2023
·
2 min read
·
Heather McKenzie
Business

BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model

Weeks after announcing a CEO shake-up and slightly decreased Q1 revenues, BMS plans to cut 48 staff members from its Princeton, NJ, facility.

May 8, 2023
·
2 min read
·
Rosemary Scott
Business

Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets Deal

Partnership seeks to identify novel therapeutic molecules to address diseases with high unmet patient needs. It’s the second target discovery company to link with BI in the last month.

May 8, 2023
·
2 min read
·
Kate Goodwin
Deals

Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks

Novel therapies often pass through several owners on their way to the market. Here’s a look at some of the drugs that got dropped before they hit primetime.

May 8, 2023
·
5 min read
·
Nadia Bey
Drug Development

Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

Ascletis Pharma Inc. announces that the China National Medical Products Administration has approved to conduct a Phase IIa clinical trial for ASC10 to treat respiratory syncytial virus infection.

May 8, 2023
·
3 min read
Opthea To Present at the JMP Securities Life Sciences Conference

Opthea Limited announced that Timothy E. Morris, the Company’s Chief Financial Officer will present at the JMP Securities Life Sciences Conference being held in New York City on May 15-16 2023.

May 8, 2023
·
2 min read
Devyser’s clinical laboratory receives CLIA certification

Devyser is announcing that the company’s clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certification.

May 8, 2023
·
2 min read
Business

Almirall’s First Quarter 2023 Results

Almirall, S.A., the global biopharmaceutical company based in Barcelona, has announced its Q1 2023 financial results.

May 8, 2023
·
11 min read